Liu et al. [16] found that LINC00665 expression was increased in lung cancer tissues and cells with acquired gefitinib resistance, and downregulation of it restored gefitinib sensitivity, indicating that LINC00665 may be involved in lung cancer progression. The gene discussed is LINC00665; the disease is lung carcinoma.